Detailed answers about NUCLEOME THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was NUCLEOME THERAPEUTICS LIMITED founded?
NUCLEOME THERAPEUTICS LIMITED was officially incorporated on 17 July 2019 and is registered under company number 12109297. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NUCLEOME THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NUCLEOME THERAPEUTICS LIMITED?
NUCLEOME THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NUCLEOME THERAPEUTICS LIMITED do?
NUCLEOME THERAPEUTICS LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is NUCLEOME THERAPEUTICS LIMITED's registered address?
The registered office address of NUCLEOME THERAPEUTICS LIMITED is NUCLEOME THERAPEUTICS LIMITED, INVENTA, BOTLEY ROAD, OXFORD, UNITED KINGDOM, OX2 0HA. This is the official address filed with Companies House for legal and statutory correspondence.
Is NUCLEOME THERAPEUTICS LIMITED financially stable?
The most recent accounts for NUCLEOME THERAPEUTICS LIMITED were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.